Phil Robinson
Ask VT AI
View News Summary
- Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
- Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
- Teenage Saracens winger Noah Caluori earns surprise England call-up after impressive Premiership debut.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
- Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
- Teenage Saracens winger Noah Caluori earns surprise England call-up after impressive Premiership debut.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Phil Robinson
News from Phil Robinson
